Tomoo Iwakuma

7.1k total citations · 2 hit papers
86 papers, 5.3k citations indexed

About

Tomoo Iwakuma is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Tomoo Iwakuma has authored 86 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 51 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Tomoo Iwakuma's work include Cancer-related Molecular Pathways (37 papers), Ubiquitin and proteasome pathways (15 papers) and Cancer Research and Treatments (13 papers). Tomoo Iwakuma is often cited by papers focused on Cancer-related Molecular Pathways (37 papers), Ubiquitin and proteasome pathways (15 papers) and Cancer Research and Treatments (13 papers). Tomoo Iwakuma collaborates with scholars based in United States, Japan and China. Tomoo Iwakuma's co-authors include Guillermina Lozano, Alejandro Parrales, Tamara Terzian, Yan Cui, Atul Ranjan, Adel K. El‐Naggar, John M. Parant, Lisa Caldwell, Yasmine A. Valentin-Vega and Young‐Ah Suh and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Tomoo Iwakuma

84 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

2004 822 citations Tomoo Iwakuma, John M. Parant et al. profile →
Mutant p53 suppresses innate immune signaling to promote tumorigenesis

2021 227 citations Alejandro Parrales, Tomoo Iwakuma et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomoo Iwakuma United States	32	3.7k	2.6k	1.3k	600	476	86	5.3k
Jonathan D. Oliner United States	21	4.2k 1.2×	3.3k 1.3×	1.1k 0.9×	687 1.1×	656 1.4×	28	6.0k
Naomi Goldfinger Israel	50	4.3k 1.2×	3.2k 1.2×	1.5k 1.2×	429 0.7×	840 1.8×	93	6.2k
Takehiko Kamijo Japan	37	5.1k 1.4×	3.2k 1.2×	1.0k 0.8×	348 0.6×	455 1.0×	114	7.1k
Margaret Ashcroft United Kingdom	34	3.2k 0.9×	1.7k 0.7×	1.7k 1.3×	320 0.5×	389 0.8×	58	4.6k
Helge Täubert Germany	42	4.3k 1.2×	2.9k 1.1×	2.3k 1.8×	1.3k 2.2×	372 0.8×	247	7.1k
Asha S. Multani United States	40	5.0k 1.4×	3.3k 1.2×	1.9k 1.4×	650 1.1×	428 0.9×	126	8.2k
Jean‐Christophe Bourdon United Kingdom	42	4.5k 1.2×	3.4k 1.3×	1.2k 0.9×	297 0.5×	767 1.6×	108	6.1k
Clemens A. Schmitt Germany	36	4.3k 1.2×	2.4k 0.9×	1.0k 0.8×	425 0.7×	480 1.0×	110	7.0k
Dawn E. Quelle United States	30	4.5k 1.2×	3.7k 1.4×	725 0.6×	470 0.8×	470 1.0×	70	6.5k
Beverly Plunkett United States	18	3.8k 1.0×	3.7k 1.4×	1.0k 0.8×	366 0.6×	1.0k 2.1×	22	5.9k

Countries citing papers authored by Tomoo Iwakuma

Since Specialization

Citations

This map shows the geographic impact of Tomoo Iwakuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoo Iwakuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoo Iwakuma more than expected).

Fields of papers citing papers by Tomoo Iwakuma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoo Iwakuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoo Iwakuma. The network helps show where Tomoo Iwakuma may publish in the future.

Co-authorship network of co-authors of Tomoo Iwakuma

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoo Iwakuma. A scholar is included among the top collaborators of Tomoo Iwakuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoo Iwakuma. Tomoo Iwakuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ohki, Rieko, Koji Itahana, & Tomoo Iwakuma. (2024). “The 10th International MDM2 Workshop”: Opening up new avenues for MDM2 and p53 research, the First International MDM2 Workshop in Asia. Genes to Cells. 29(6). 451–455. 1 indexed citations

Iwakuma, Tomoo, et al.. (2024). Therapeutic potential of combating cancer by restoring wild-type p53 through mRNA nanodelivery. Nanomedicine Nanotechnology Biology and Medicine. 56. 102732–102732. 9 indexed citations

Li, Jin, He Zhang, Zhenhe Wang, et al.. (2023). 8-oxo-dGTP curbs tumor development via S phase arrest and AIF-mediated apoptosis. Free Radical Biology and Medicine. 196. 53–64. 3 indexed citations

Gonzalez, Elizabeth M., Atif Ahmed, Katherine Chastain, et al.. (2023). Perinucleolar Compartment (PNC) Prevalence as an Independent Prognostic Factor in Pediatric Ewing Sarcoma: A Multi-Institutional Study. Cancers. 15(8). 2230–2230. 2 indexed citations

Zhang, Wei, Yue Zhao, Qian Liu, et al.. (2023). Colonic L-cell impairment in aged subjects with type 2 diabetes leads to diminished GLP-1 production. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 17(12). 102907–102907. 4 indexed citations

Ranjan, Atul, Satomi Yamamoto, Atsushi Kaida, et al.. (2022). Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin. Cancers. 14(17). 4187–4187. 16 indexed citations

Nishikawa, Shigeto, Atsushi Kaida, Alejandro Parrales, et al.. (2022). DNAJA1- and conformational mutant p53-dependent inhibition of cancer cell migration by a novel compound identified through a virtual screen. Cell Death Discovery. 8(1). 437–437. 9 indexed citations

Young, Eric D., Sharon Manley, Thomas C. Beadnell, et al.. (2020). Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5. British Journal of Cancer. 124(1). 166–175. 13 indexed citations

Dong, Shengli, Somesh Baranwal, Anapatricia García, et al.. (2017). Nischarin inhibition alters energy metabolism by activating AMP-activated protein kinase. Journal of Biological Chemistry. 292(41). 16833–16846. 20 indexed citations

10.

Liang, Yan, Robert C. Lyon, Jason Pellman, et al.. (2016). Abstract 20108: A Newly Identified Interaction Between Desmoplakin and COP9 Signalsome Subunit 6 Reveals a New Mechanism Underlying Sudden Death. Circulation. 134. 1 indexed citations

11.

Liu, Wen, Benjamin H. Beck, Kedar S. Vaidya, et al.. (2013). Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis. Cancer Research. 74(3). 954–963. 69 indexed citations

12.

Cui, Yan, Ryoko Kibe, Shuzhong Zhang, et al.. (2012). IL-7R{alpha} deficiency in p53null mice exacerbates thymocyte telomere erosion and lymphomagenesis. The Journal of Immunology. 188. 1 indexed citations

13.

Kibe, Ryoko, Luis Marrero, Fern Tsien, et al.. (2012). IL-7Rα deficiency in p53null mice exacerbates thymocyte telomere erosion and lymphomagenesis. Cell Death and Differentiation. 19(7). 1139–1151. 16 indexed citations

14.

Agarwal, Neeraj, et al.. (2012). MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4. Oncogene. 32(4). 462–470. 46 indexed citations

15.

Cui, Yan, Shuzhong Zhang, Mingquan Zheng, et al.. (2011). Trp53 negatively regulates autoimmunity via the STAT3-Th17 axis (167.27). The Journal of Immunology. 186(1_Supplement). 167.27–167.27. 1 indexed citations

16.

Adhikari, Amit S., et al.. (2010). CD117 and Stro-1 Identify Osteosarcoma Tumor-Initiating Cells Associated with Metastasis and Drug Resistance. Cancer Research. 70(11). 4602–4612. 216 indexed citations

17.

Iwakuma, Tomoo, Yuki Tochigi, Carolyn S. Van Pelt, et al.. (2007). Mtbp haploinsufficiency in mice increases tumor metastasis. Oncogene. 27(13). 1813–1820. 26 indexed citations

18.

Iwakuma, Tomoo, John M. Parant, Edwin Zwart, et al.. (2004). Mutation at p53 serine 389 does not rescue the embryonic lethality in mdm2 or mdm4 null mice. Oncogene. 23(46). 7644–7650. 18 indexed citations

19.

Iwakuma, Tomoo, Yan Cui, & Lung-Ji Chang. (1999). Self-Inactivating Lentiviral Vectors with U3 and U5 Modifications. Virology. 261(1). 120–132. 145 indexed citations

20.

Tsuzuki, Teruhisa, Kunihiko Sakumi, Hisaya Kawate, et al.. (1996). ACCELERATED PAPER: Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent. Carcinogenesis. 17(6). 1215–1220. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact